Andrew D'Amico sold $360k of VICR
director at VICOR CORP. 6,200 shares at an average of $58.03, traded Jan 21, 2025, filed Jan 23, 2025.
Score components
- +15RoleDirector
- +15Trade size$360k at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +10.4%, 3m -12.1%, 6m -18.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001830195-25-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | MOption exercise Common Stock10b5-1 | +1,200 | $16.15 | $19k | 1,200 | Jan 23, 2025 |
| Jan 21, 2025 | SOpen-market sale Common Stock10b5-1 | -1,200 | $54.00 | $65k | 0 | Jan 23, 2025 |
| Jan 21, 2025 | MOption exercise Common Stock10b5-1 | +1,000 | $16.15 | $16k | 1,000 | Jan 23, 2025 |
| Jan 21, 2025 | SOpen-market sale Common Stock10b5-1 | -1,000 | $56.00 | $56k | 0 | Jan 23, 2025 |
| Jan 22, 2025 | MOption exercise Common Stock10b5-1 | +1,000 | $16.15 | $16k | 1,000 | Jan 23, 2025 |
| Jan 22, 2025 | SOpen-market sale Common Stock10b5-1 | -1,000 | $58.00 | $58k | 0 | Jan 23, 2025 |
| Jan 22, 2025 | MOption exercise Common Stock10b5-1 | +1,000 | $16.15 | $16k | 1,000 | Jan 23, 2025 |
| Jan 22, 2025 | SOpen-market sale Common Stock10b5-1 | -1,000 | $60.00 | $60k | 0 | Jan 23, 2025 |
| Jan 22, 2025 | MOption exercise Common Stock10b5-1 | +1,000 | $39.25 | $39k | 1,000 | Jan 23, 2025 |
| Jan 22, 2025 | SOpen-market sale Common Stock10b5-1 | -1,000 | $60.00 | $60k | 0 | Jan 23, 2025 |
| Jan 22, 2025 | MOption exercise Common Stock10b5-1 | +1,000 | $39.25 | $39k | 1,000 | Jan 23, 2025 |
| Jan 22, 2025 | SOpen-market sale Common Stock10b5-1 | -1,000 | $61.00 | $61k | 0 | Jan 23, 2025 |
| Jan 21, 2025 | MOption exercise Non Qualified Stock Optionderivative10b5-1 | -2,200 | $0.00 | $0 | 3,000 | Jan 23, 2025 |
| Jan 22, 2025 | MOption exercise Non Qualified Stock Optionderivative10b5-1 | -2,000 | $0.00 | $0 | 1,000 | Jan 23, 2025 |
| Jan 22, 2025 | MOption exercise Non Qualified Stock Optionderivative10b5-1 | -2,000 | $0.00 | $0 | 8,000 | Jan 23, 2025 |
Related signals
Other insiders at VICOR CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | VICOR CORP | Philip D Davies Corp. VP-Global Sales & Mktg. | $972k 3,072 shares | -62% | |
| 38Weak | VICOR CORP | Patrizio Vinciarelli Chairman & CEO | $6.3M 20,000 shares | -0% | |
| 38Weak | VICOR CORP | Patrizio Vinciarelli Chairman & CEO | $6.2M 20,000 shares | -0% | |
| 19Weak | VICOR CORP | Philip D Davies Corp. VP-Global Sales & Mktg. | $546k 3,073 shares | -62% | |
| 48Moderate | VICOR CORP | Zmira Lavie director | $227k 908 shares | -100% | |
| 58Moderate | VICOR CORP | Samuel J Anderson director | $524k 2,073 shares | -34% | |
| 35Weak | VICOR CORP | Philip D Davies Corp. VP-Global Sales & Mktg. | $650k 3,072 shares | -62% | |
| 41Moderate | VICOR CORP | Zmira Lavie director | $273k 1,216 shares | -100% | |
| 32Weak | VICOR CORP | Patrizio Vinciarelli Chairman & CEO | $212k 700 shares | -0% | |
| 40Moderate | VICOR CORP | Philip D Davies Corp. VP-Global Sales & Mktg. | $1.1M 3,073 shares | -62% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.